poisar

Stocks · News reference

Lifeward Appoints Josh Hexter As Interim CEO, Succeeding Mark Grant, Effective September 1; Names Rami Aviram CFO Effective November 1

BenzingaBenzinga Newsdesk

Lifeward Ltd. (NASDAQ:LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncResearchandmarkets.Com

    Global Walk Assist Robot Market Research Report and Strategic Forecast 2026-2031 | AI and Hybrid Wearables Expand Clinical and Home-Care Growth Opportunities

    The global walk assist robot market is projected to grow at a CAGR of 15.01% from 2024 to 2031, driven by AI/ML integration, hybrid wearable systems, rising stroke incidence, and an aging population. Key applications include neuro-rehabilitation, post-surgical rehabilitation, and elderly mobility assistance. North America leads with 39% market share, while Asia-Pacific shows sustained growth potential. High costs and regulatory challenges remain market restraints.

  2. SEC EDGARSEC EDGAR

    8-K filing — Lifeward Ltd. (LFWD)

    Filed: 2026-11-13 AccNo: 0001178913-26-005208 Size: 395 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits